Skip to main content
. 2020 Feb 7;20:24. doi: 10.1186/s12874-020-0906-6

Table 9.

Comparison of therapy effectiveness for the relapse model

DMT* Slope coefficienta Sample size when DMT* was taken Sample size when DMT* was not taken p-value
Dimethylfumarat −0.6918 134 307 0.016
Fingolimod 0.0423 128 112 0.860
Natalizumab −0.4376 234 2182 0.019

DMT* highest ranked disease modifying therapy.

a Derived from a survey-weighted negative binomial generalized linear model where negative sign indicates lower disease activity